AusperBio raised $73 million in a Series B funding round led by HanKang Capital to advance the development of targeted oligonucleotide therapies for chronic hepatitis B.
Amount Raised
$73 Million
Round Type
Series B
Investors
Description
AusperBio announced the completion of a $73 million Series B funding round with participation from various investors. The funds will be used to support the continued development of its lead investigational therapy AHB-137, along with expanding its therapeutic pipeline and operational capabilities.
Quick answer
AusperBio raised $73 Million in a Series B round, dated December 27, 2024. Investors: InnoPinnacle Fund, Yuanbio Venture Capital, Hankang Capital, Qiming Venture Partners, CDH Investments and Sherpa Capital.
- How much did AusperBio raise?
- AusperBio raised $73 Million in a Series B round on December 27, 2024.
- Who invested in AusperBio?
- InnoPinnacle Fund, Yuanbio Venture Capital, Hankang Capital, Qiming Venture Partners, CDH Investments and Sherpa Capital are named as investors in this round.
- What does AusperBio do?
- AusperBio is a clinical-stage biopharmaceutical company with operations in the USA and China, dedicated to advancing oligonucleotide and targeted delivery technologies for transformative therapies, with an initial focus..
- Where is AusperBio based and how big is it?
- Fundz records about 100 employees.
- Who are the decision-makers at AusperBio?
- Fundz holds 4 contacts at AusperBio, including the Co-Founder & CEO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biopharma around the same time
Companies in the same sectors as AusperBio that raised within 45 days of this round, from Fundz verified event records.
- Acasti raised $15M on February 10, 2025.
- NRx Pharmaceuticals raised $3.5M (Seed) on January 27, 2025.
- Windward Bio raised $200M (Series A) on January 10, 2025.
- Verdiva Bio raised $411M (Series A) on January 9, 2025.
- Os Therapies raised $6M (Post-IPO Equity) on December 31, 2024.
- Os Therapies raised $7.1M on December 31, 2024.
Who to call at AusperBio, and when
A new round usually means AusperBio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day AusperBio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AusperBio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AusperBio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AusperBio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAusperBio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.